1 Wolffenbuttel BHR et al.: The Many Faces of Cobalamin (Vitamin B12) Deficiency. Mayo Clin Proc Inn Qual Out 2019; 3(2): 200-214
2 Didangelos T et al.: Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2021 Jan 27; 13(2): 395
3 Agathos E et al.: Effect of alpha-lipoic acid on symptoms and quality life in patients with painful diabetic neuropathy. J Intern Med Research 2018; 46(5): 1779-1790
4 Stirban OA et al.: Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months. J Diabetes complications 2020 Dec; 34(12): 107757
5 Fei S et al.: Vitamin D deficiency increases the risk of diabetic peripheral neuropathy in elderly type 2 diabetes mellitus patients by predominantly increasing large-fiber lesions. Diabetes Res Clin Pract 2024 Mar; 209: 111585
6 Holick MF: Bioavailability of Vitamin D and its metabolites in black and white adults. In: New England Journal of Medicine. Band 369, Ausgabe 21 vom 21. November 2013, S. 2047-2048
7 Pludowski P et al.: Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. Nutrients 2022 Apr 2; 14(7): 1483
8 Classen HG et al.: Hypervitaminose D, Hyperkalzämie und die Rolle von Magnesium. Nieren- und Hochdruckkrankheiten 2022; 51(11): 446-451
9 Asif A, Farooq N: Vitamin D Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. 2023 May 24
10 Pludowski P et al.: Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 microg) of Vitamin D for Adults in the General Population. Nutrients 2024; 16(3)

Seite 38: Phytotherapie, Yoga und Akupunktur in der Gastroenterologie – Alles nur Humbug oder mögliche Therapieansätze?
1. Attaluri A, Donahoe R, Valestin J, Brown K, Rao SS (2011): Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment PharmacolTher33(7):822–828
2. Moayyedi P, Quigley EM, Lacy BE et al (2014): The effect of fiber supplementation on irritable bowel syndrome: a systematic review andmeta-analysis. AmJGastroenterol 109(9):1367–1374
3. Gunn D, Abbas Z, Harris HC et al (2022): Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies. Gut 71(5):919–927
4. WongC,Harris PJ, Ferguson LR(2016): Potential benefits ofdietary fibre intervention in inflammatory bowel disease. Int JMol Sci 17(6):919
5. Gearry R, Fukudo S, Barbara G et al (2023): Consumption of 2 green kiwifruits daily improves constipation and abdominal comfort-results of an internationalmulticenter randomized controlled trial.AmJGastroenterol 118(6):1058–1068
6. Langhorst J, Varnhagen I, Schneider SB et al (2013): Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double-blind, double-dummy study. Aliment Pharmacol Ther 38(5):490–500
7. Biedermann L, Mwinyi J, Scharl M et al (2013): Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study. J CrohnsColitis 7(4): 271–279
8. Hanai H, Iida T, Takeuchi K et al (2006): Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4(12):1502–1506
9. Kumar S, Ahuja V, Sankar MJ, Kumar A, Moss AC (2012): Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 10:CD8424
10. Lang A, Salomon N, Wu JC et al (2015): Curcumin in combination withmesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol. Hepatol13(8):1444–1449.e1
11. Ben-Horin S, Salomon N, Karampekos G et al (2023): Curcumin-Qing Dai combination for patients with active ulcerative colitis: a randomized double-blinded placebo-controlled trial. Clin Gastroenterol Hepatol.
12. Yanai H, Salomon N, Lahat A et al (2023): Real-world experience with Curcumin-QingDai combination for patients with active ulcerative colitis: a retrospective multicentre cohort study. Aliment Pharmacol Ther 58(2):175–181
13. Black CJ, Yuan Y, Selinger CP et al (2020): Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 5(2): 117–131
14. Rich G, Shah A, Koloski N et al (2017): A randomized placebo-controlled trial on the effects of menthacarin, a proprietary peppermint- and carawayoil-preparation, on symptoms and quality of life in patients with functional dyspepsia. Neurogastroenterol Motil.
 15. Madisch A, Frieling T, Zimmermann A et al (2023): Menthacarin, a proprietary peppermint oil and caraway oil combination, improves multiple complaints in patients with functional gastrointestinaldisorders: asystematic reviewand meta-analysis.DigDis 41(3):522–532
16. Schumann D, Anheyer D, Lauche R, Dobos G, Langhorst J, Cramer H (2016): Effect of yoga in the therapy of irritable bowel syndrome: a systematic review. Clin Gastroenterol Hepatol 14(12):1720–1731
17. Nunan D, Cai T, Gardener AD et al (2022): Physical activity for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 6 (6):CD11497
18. D’Silva A, Marshall DA, Vallance JK et al (2023): Meditation and yoga for irritable bowel syndrome: a randomized clinical trial. Am J Gastroenterol 118(2):329–337
19. D’Silva A, Marshall DA, Vallance JK et al (2023): Gastroenterologist and patient attitudes toward yoga as a therapy for irritable bowel syndrome: an application of the theory of planned behaviour. JCanAssocGastroenterol 6(1):17–25
20. Cramer H, Schafer M, Schols M et al (2017): Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis. Aliment Pharmacol Ther 45(11):1379–1389
21. Sharma P, Poojary G, Dwivedi SN, Deepak KK(2015): Effect of yoga-based intervention in patientswith inflammatory bowel disease. Int J Yoga Therap 25(1):101–112
22. Torres J, Ellul P, Langhorst J et al (2019): European Crohn’s and colitis organisation topical review on complementarymedicine and psychotherapy in inflammatory bowel disease. J Crohns Colitis 13(6):673–685e
23. Manheimer E, Wieland LS, Cheng K et al (2012): Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol107(6):835–847
24. Lembo AJ, Conboy L, Kelley JM et al (2009): A treatment trial of acupuncture in IBS patients. AmJGastroenterol 104(6):1489–1497
25. Yang Y, Rao K, Zhan K et al (2022): Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Public Health 10:1022145
26. Johannesson E, SimrenM, StridH,Bajor A, SadikR (2011): Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 106(5):915–922
27. Zhou C, Zhao E, Li Y, Jia Y, Li F (2019): Exercise therapy of patients with irritable bowel syndrome: a systematic review of randomized controlled trials. Neurogastroenterol Motil 31(2):e13461
28. Khalili H, Ananthakrishnan AN, Konijeti GG et al (2013): Physical activity and risk of inflammatory bowel disease: prospective study fromthe nurses’ health study cohorts. BMJ347:f6633
29. Klare P, Nigg J, Nold J et al (2015): The impact of a ten week physical exercise program on health-related quality of life in patientswith inflammatory bowel disease: a prospective randomized controlled trial. Digestion91(3):239–247
30. Lo CH, Khalili H, Song M et al (2021): Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin GastroenterolHepatol 19(1):87–95.e4
31. Jones PD, Kappelman MD, Martin CF, Chen W, Sandler RS, Long MD (2015): Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm BowelDis21(5):1063–1071
32. Ananthakrishnan AN, Kaplan GG, Bernstein CN et al (2022): Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel  siseases: an international organization for study of inflammatory bowel diseases consensus. Lancet Gastroenterol Hepatol 7(7):666–678
33. Lamas K, Lindholm L, Stenlund H, Engstrom B, Jacobsson C (2009): Effects of abdominal massage in management of constipation – a randomized controlled trial. Int JNurs Stud 46(6):759–767
34. Birimoglu Okuyan C, Bilgili N (2019): Effect of abdominal massage on constipation and quality of life in older adults: a randomized controlled trial. ComplementTherMed47:102219
35. McClurg D, Harris F, Goodman K et al (2018): Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: aRCT. Health Technol Assess 22(58):1–134
36. Mimidis K, Galinsky D, Rimon E, Papadopoulos V, Zicherman Y, Oreopoulos D (2005): Use of  device that applies external kneading-like force on the abdomen for treatment of constipation. World J Gastroenterol11(13):1971–1975
37. Janssen TW, Prakken ES, Hendriks JM, Lourens C, van der Vlist J, Smit CA (2014): Electro mechanical abdominal massage and colonic function in individuals with a spinal cord injury and chronic bowel problems. SpinalCord52(9):693–696
38. Zhu JH, Qian YY, Pan J et al (2022): Efficacy and safety of vibrating capsule for functional constipation (VICONS): a randomised, double-blind, placebo controlled, multicenter trial. E Clinical Medicine 47:101407
39. Rao SSC, Lembo A, Chey WD, Friedenberg K, Quigley EMM (2020): Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation. Neurogastroenterol Motil 32(11):e13890